Cargando…

Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China

The increasing incidence of carbapenem-resistant Enterobacteriaceae (CRE) - mediated hospital infections in China prompted a need to investigate the genetic basis of emergence of such strains. A nationwide survey was conducted in China covering a total of 1105 CRE strains collected from 25 geographi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Rong, Liu, Lizhang, Zhou, Hongwei, Chan, Edward Waichi, Li, Jiaping, Fang, Ying, Li, Yi, Liao, Kang, Chen, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440625/ https://www.ncbi.nlm.nih.gov/pubmed/28479289 http://dx.doi.org/10.1016/j.ebiom.2017.04.032

Ejemplares similares

Cost-effectiveness of carbapenem-resistant Enterobacteriaceae (CRE) surveillance in Maryland
por: Lin, Gary, et al.
Publicado: (2022)

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
por: Suay-García, Beatriz, et al.
Publicado: (2019)

Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection
por: Lin, Qun, et al.
Publicado: (2021)

1432. Population-based Surveillance of Carbapenem-Resistant Enterobacteriaceae (CRE) in Alameda County, 2017-2020
por: Horwich-Scholefield, Sam, et al.
Publicado: (2020)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Campbell, Eileen, et al.
Publicado: (2019)

Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019
por: Huang, Hong, et al.
Publicado: (2020)

359 Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) at an Academic Medical Center
por: Leiner, Charles, et al.
Publicado: (2014)

1249. Emergence of Diverse Carbapenem-Resistant Enterobacteriaceae (CRE) in the Dominican Republic
por: Fermin, Rita Rojas, et al.
Publicado: (2018)

Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice
por: Zhang, Zhijie, et al.
Publicado: (2022)

499. Carbapenem-resistant Enterobacteriaceae (CRE)-associated Infections and Prolonged Colonization among Hospitalized Patients Colonized by CRE
por: Khawcharoenporn, Thana, et al.
Publicado: (2019)

533. Impact of Different Definitions on Reported Rates of Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Passaretti, Catherine, et al.
Publicado: (2019)

509. The Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) in a Community Hospital Setting
por: Lewis, Sally, et al.
Publicado: (2019)

Genetic Diversity of Carbapenem-Resistant Enterobacteriaceae (CRE) Clinical Isolates From a Tertiary Hospital in Eastern China
por: Miao, Minhui, et al.
Publicado: (2019)

Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from Blood by Heparin-Functional Hemoperfusion Media
por: McCrea, Keith, et al.
Publicado: (2014)

Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome
por: Madney, Youssef, et al.
Publicado: (2023)

Endogenous Bacteremia Caused by Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae (CRE) in Immunocompromised Children
por: Almasian Tehrani, Nasim, et al.
Publicado: (2023)

Carbapenem-resistant Enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance study
por: Adesanya, Oluwafolajimi Adetoye, et al.
Publicado: (2020)

Treatment of Ventriculitis and Meningitis After Neurosurgery Caused by Carbapenem-Resistant Enterobacteriaceae (CRE): A Challenging Topic
por: Li, Cuiling, et al.
Publicado: (2023)

Epidemiologic Patterns and Clinical Implications of Genotypic Resistance Mechanism for Carbapenem-Resistant Enterobacteriaceae (CRE)Surveillance Isolates from Los Angeles County
por: Bhaurla, Sandeep, et al.
Publicado: (2017)

Predictors of carbapenem-resistant Enterobacteriaceae (CRE) strains in patients with COVID-19 in the ICU ward: a retrospective case–control study
por: Vlad, Nicoleta-Dorina, et al.
Publicado: (2022)

355 Carbapenem-Resistant Enterobacteriaceae (CRE) Distribution within the Veterans Affairs Healthcare System: 2013
por: Ryono, Russell, et al.
Publicado: (2014)

843. Increased Carbapenemase Testing Following Implementation of VA Guidelines for Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Fitzpatrick, Margaret A, et al.
Publicado: (2020)

CaseFinder: A Flexible Real-time Online Surveillance Registry for Infectious Disease Physicians to Report Cases of Carbapenem-resistant Enterobacteriaceae (CRE)
por: Curtis, Donald, et al.
Publicado: (2013)

532. Can Saccharomyces boulardii Therapy Be Effective in Decolonizing Rectal Carbapenem-Resistant Enterobacteriaceae (CRE) Colonization?
por: Resat Sipahi, Oguz, et al.
Publicado: (2019)

2130. Detection of Carbapenemase-Producing Organisms and Impact on Antimicrobial Utilization for Carbapenem-Resistant Enterobacteriaceae (CRE) Infections
por: Minor, Sarah Brooks, et al.
Publicado: (2019)

2276. Clinical Epidemiology of the Carbapenem-Resistant Enterobacteriaceae (CRE) Epidemic in Colombia: A Multicenter Prospective Study
por: Valderrama-Beltrán, Sandra Liliana, et al.
Publicado: (2019)

1591. Antibiotic Utilization Trends in Veterans Affairs (VA) Patients with Carbapenem Resistant Enterobacteriaceae (CRE) Infections
por: Traversa, Alfredo, et al.
Publicado: (2020)

1178. A Multicenter Prospective Study of Clinical and Molecular Epidemiological Analysis of Carbapenem-Resistant Enterobacteriaceae (CRE) and Carbapenemase-Producing Enterobacteriaceae (CPE) in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2018)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

1726 What Defines Carbapenem-Resistant Enterobacteriaceae (CRE) in a Low Prevalence State? Oregon, 2010 — 2013
por: Maureen Cassidy, P., et al.
Publicado: (2014)

2167. Predicting Carbapenem-Resistant Enterobacteriaceae (CRE) Carriage on Admission using Updated Statewide Hospital Discharge Data
por: Ray, Michael J, et al.
Publicado: (2018)

1251. Contaminated Sinks May be an Environmental Source for Serial Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE) to ICU Patients
por: Lewis, Sarah S, et al.
Publicado: (2018)

2247. Real-world Experience with Meropenem–Vaborbactam (M/V) for Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections
por: Shields, Ryan K, et al.
Publicado: (2019)

710. In Vitro Activity and Performance of Available Susceptibility Testing Methods for Eravacycline Against Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Jones, Chelsea E, et al.
Publicado: (2019)

Instituting Public Health Laboratory Surveillance for Methicillin-resistant Staphylococcus aureus (MRSA), Extended-Spectrum Β Lactamase producing Enterobacteriaceae (ESBL), and Carbapenem-resistant Enterobacteriaceae (CRE) in a Large Metropolitan County
por: O’Donnell, Kathleen, et al.
Publicado: (2017)

Genomically Informed Surveillance for Carbapenem-Resistant Enterobacteriaceae in a Health Care System
por: Pecora, Nicole D., et al.
Publicado: (2015)

Carbapenem-Nonsusceptible Enterobacteriaceae in Taiwan
por: Wang, Jann-Tay, et al.
Publicado: (2015)

Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China
por: Yang, Xuemei, et al.
Publicado: (2022)

Bacteremia due to Carbapenem-Resistant Enterobacteriaceae (CRE) in New York and New Jersey: A Clinical and Molecular Epidemiologic Analysis
por: Satlin, Michael, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qtd0l288ithlr4dnhub57bnpvo